Ticker
CSBR
Analysis
Champions Oncology, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to CSBR.
Champions Oncology, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to CSBR.
CSBR
Stock
$87.8M
Health Technology
Biotechnology
USD
Champions Oncology, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
Appointment underscores Champions' focus on leveraging clinically relevant data to power next-generation oncology R&D HACKENSACK, NJ / ACCESS Newswire / March
Company remains on track to deliver year-over-year revenue growth and positive adjusted EBITDA for the fiscal year HACKENSACK, NJ / ACCESS Newswire / March 12, 2026 / Champions ...
HACKENSACK, NJ / ACCESS Newswire / March 5, 2026 / Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will report its
We remain on track to deliver year-over-year revenue growth and to generate positive adjusted EBITDA for the fiscal year HACKENSACK, NJ / ACCESS Newswire / December 15, 2025 / C...
HACKENSACK, NJ / ACCESS Newswire / December 8, 2025 / Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will report its financial and oper...
Review valuation context for Champions Oncology, Inc..
Review future growth context for Champions Oncology, Inc..
Review past performance context for Champions Oncology, Inc..
Review financial health context for Champions Oncology, Inc..
Review dividend context for Champions Oncology, Inc..
Review management context for Champions Oncology, Inc..
Review ownership context for Champions Oncology, Inc..
Review other information context for Champions Oncology, Inc..
Review community context for Champions Oncology, Inc..